Studies that recruit patients with established TID treated with MDI, may show an improvement with insulin pump therapy for two reasons: (1) selection bias, since patients with good glycaemic control who are satisfied with MDI therapy are less likely to be approached or agree to participate in these studies and (2) increased contact with diabetes health-care professionals because at the start of insulin pump therapy patients receive an intensive period of education. Here, INS is linked to diabetes mellitus.